Genetically identical twin transplantation for chronic lymphocytic leukemia (VSports手机版)
- PMID: 17728782
- DOI: 10.1038/sj.leu.2404928 (VSports注册入口)
Genetically identical twin transplantation for chronic lymphocytic leukemia
Abstract
We identified 19 persons with B-cell chronic lymphocytic leukemia (CLL) who received genetically identical twin blood cell or bone marrow transplants after high-dose conditioning. Ten are alive (eight disease-free) with a median follow-up of 89 months (range, 31-171 months); 5-year relapse rate was 50% (95% confidence interval (CI), 26-73%). Estimated 5-year survival and disease-free survival were 61% (95% CI, 37-82%) and 45% (95% CI, 23-68%). In two of four patients tested at 12 and 21 months by polymerase chain reaction no evidence of residual CLL was detected post-transplant VSports手机版. In one recipient who relapsed at 6 years, molecular studies showed a different CLL clone from that detected pretransplant. This clone was subsequently identified in the donor suggesting transfer of occult leukemia at the time of transplant. Genetically identical twin transplants can result in long-term disease-free survival and molecular remissions, these data suggest the potential for CLL control in the absence of allogeneic graft-versus-leukemia effect. The case of leukemia transfer indicates the need for careful evaluation of donors prior to graft collection. .
Publication types
MeSH terms (VSports手机版)
- Actions (V体育2025版)
- "VSports在线直播" Actions
- "VSports最新版本" Actions
- "V体育ios版" Actions
- "VSports app下载" Actions
- "VSports在线直播" Actions
- "VSports最新版本" Actions
- Actions (VSports手机版)
- V体育平台登录 - Actions
Substances
- Actions (VSports注册入口)
"V体育ios版" Grants and funding
LinkOut - more resources
Full Text Sources
"VSports注册入口" Other Literature Sources
Medical
